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In recent years the nonspecific plant mitogens phytohemagglutinin (PHA),  1 con- 
canavalin A  (Con A), and pokeweed mitogen (PWM)  have been widely used to in- 
vestigate fundamental problems in lymphocyte biology. The sequence of events after 
activation of lymphocytes by these substances is similar to the sequence which follows 
an  encounter  with  specific antigen.  The  activation by  mitogens  of  a  majority of 
lymphocytes of a  particular type, contrasted with the very limited number  of cells 
specifically  stimulated by antigen, provides a powerful tool for study of the events and 
consequences of lymphocyte activation. The heterogeneity of lymphoid cells as re- 
flected by their proliferative responses to  mitogens has  recently been  an  object of 
considerable interest in several laboratories. It is now generally agreed that soluble 
Con A  and PHA exclusively stimulate thymus-derived lymphocytes (T cells) (1-4). 
Conversely, when these T  cell mitogens are covalently bound to certain particulate 
carriers such as sepharose beads (5)  or plastic Petri dishes (6), bone marrow-derived 
lymphocytes (B cells) are activated. Con A is also reported to activate B  cells in the 
presence of supernates from  Con A-stimulated T  cells (4).  PWM is apparently less 
specific and stimulates both T  and B lymphocytes (2). 
The consequences of T  cell activation by mitogen have been the more intensively 
investigated. The  morphological events  of  blast  transformation  and  mitosis  were 
recognized first (7). Recently attention has focused on the differentiation of mitogen- 
stimulated T  cells for  performance  of  the  diverse functions  of  frilly differentiated 
antigen-stimulated T  lymphocytes. In this regard it has been reported that  Con A 
and  PHA  stimulate  production  of  mediators  of  delayed hypersensitivity such  as 
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skin-reactive factor (8, 9), migration inhibitory factor (10), and lymphotoxin (11, 12). 
Moreover,  it has  been shown that  these  substances can induce development of  a 
population of cytotoxic lymphocytes, or "killer cells" (13-15). 
It is now apparent that development of an antibody response to  complex, 
multideterminant antigens requires a cooperative interaction between lympho- 
cytes of thymus and bone marrow derivation (16). Antibody synthesis per se is 
an exclusive property of B lymphocytes, whereas T  cells function in a permissive 
or  "helper"  capacity which is as  yet poorly understood. Under physiological 
conditions the activities of both cell types are antigen dependent and antigen 
specific  (17).  Although  it  is  clear  that  mitogens can  nonspecifically replace 
antigen stimulation for many cellular immune functions, it is not dear whether 
they can similarly activate or modulate helper T  cell activity for humoral im- 
munity. The studies to be reported were undertaken to examine the effects of 
nonspecific mitogen-induced activation of lymphocytes on antibody s)mthesis 
in vitro. 
Materials and Methods 
Mice.--Ma]e  C57BL/6J  and BALB/cJ  mice were obtained  from Jackson  Laboratory, 
Bar Harbor, Maine, and maintained on laboratory chow and acidified-chlorinated water ad 
lib. Experiments were performed with 8- to 16-wk old animals. 
Milogens.--Twice  recrystallized  concanavalin  A  (Con A)  (Nutritional  Biochemicals 
Corporation, Cleveland, Ohio) was stored at room temperature  in saturated  NaCI solution 
and sterilized by filtration through a 0.45 #m Millipore membrane (Mi]lipore Corporation, 
Bedford, Mass.) saturated  with Con A. Sterile phytohemagglutinin-P  (PHA-P)  (Wellcome 
Reagents, Ltd.,  Beckenham, England) and pokeweed mitogen (PWM)  (Grand Island Bio- 
logical Co., Grand Island,  1%.  Y.) were stored in lyophillzed form at  --20°C. All mitogens 
were diluted with Hanks' balanced salt solution (HBSS) before use and were subsequently 
stored at 4°C and used within 1 wk of dilution. 
Erythrocyte Antigens.--Sheep  (SRBC) and horse (HRBC) erythrocytes  (Grand  Island 
Biological Co.) were obtained  in Alsever's solution and washed three  times in HBSS by 
centrifugafion before use. 
Spleen Cell Cultures.--Preparation of spleen cell suspensions and techniques of cell culture 
have been described in detail previously (18-20). Briefly, single cell suspensions of spleens 
were prepared  by gentle  teasing and sedimentation  of tissue fragments  and debris. Cells 
cultured for antibody synthesis were suspended in Eagle's minimal essential medium, sup- 
plemented with  L-glutamlne, aaonessential amino  acids, sodium pyruvate,  and  10%  fetal 
bovine serum (Reheis Co., Inc., Kankakee, IlL; lot E21806) and containing penicillin, strepto- 
mycin, and nystatin. Cultures were established at 107 spleen cells per ml with 107 heterologous 
erythrocytes.  1-ml cultures were maintained in 35-ram plastic Petri dishes (Falcon Plastics, 
Oxnard, Calif.) at 37°C on a continuously rocking platform in a humidified atmosphere of 
10% CO2, 7% 02, and 83% Nz  (19). Experimental groups contained three cultures which 
were pooled for assay of hemolytic plaque-forming cells. Cells cultured for DNA synthetic 
responses to mitogens were maintained in triplicate as 1-ml cultures in 12  X 75 mm plastic 
tubes (Falcon Plastics) containing 106 cells in RPMI-1640 medium supplemented with L-gluta- 
mine and 5% fetal  bovine serum and containing penicillin, streptomycin, and nystatin at 
37°C in a humidified atmosphere of 5% CO2 in air (20). ROBERT  R.  RICK  AND  CARL W.  PIERCE  207 
Ilemolytic  Plaque Assay.--The  plaque-forming cell  (PFC)  response of cultured cells was 
assayed by enumerating IgM or IgG antibody-producing cells by the slide modification of the 
localized  hemolysis-in-gel technique of  Jerne  previously described  (19). Three  slides were 
prepared from pooled cultures in experimental groups and PFC responses are expressed as 
the mean PFC per culture. To permit pooling of data from replicate experiments with differ- 
ing control PFC responses, control data were normalized to responses of 1,000 IgM or 200 
IgG PFC per culture and experimental data were derived by multiplying observed responses 
by the normalization factor. 
Tritiated  Thymldine Incorporation.--The  incorporation of tritiated thymidine  ([3H]TdR) 
(Schwarz/Mann, Orangeburg, N. Y.)  into DNA in mitogen-stimulated cultures was assayed 
by adding 1.0/~Ci  of the isotope to cultures for the final  18 h of a 72-h culture period. Cells 
from individual cultures were harvested on 0.45-#m  Millipore membranes and washed once 
with cold phosphate-buffered saline containing 1 mM unlabeled thymidine (Schwarz/Mann), 
twice with cold  5%  trichloroacetic acid  containing 1 mM  unlabeled thymidine, and  once 
with cold 95% ethanol. Dry filter membranes were placed in Aquasol (New England Nuclear 
Corp., Boston, Mass.) and radioactivity was assayed in a Beckman liquid scintillation spec- 
trometer (Beckman Instruments, Inc., Fullerton, Calif.)  Data are expressed as mean counts 
per minute (cpm)  of triplicate cultures. 
Cell Enumeration  and  Viability  Determination.--Nucleated  cells were enumerated with a 
Model B  Coulter Counter (Coulter Electronics, Hialeah, Fla.). Cell viability was determined 
by trypan blue exclusion; cells were stained for 30 s in 0.04% trypan blue, fixed with an equal 
volume of 4% acetic acid, and counted in a hemacytometei. 
Iodination  o] Con A.--Con A was iodinated by a modification of the method of Greenwood, 
Hunter, and Glover (21). 5 mg Con A in 200/zl saturated NaC1 were added to 1 mCi carrier- 
free [125I]Na (New England Nuclear Corp.) at 4°C. 20 #1 chloramine-T (5 mg/ml) (Eastman 
Kodak Co.,  Rochester, N.  Y.)  and 20 #1 0.5 M  phosphate buffer pH 7.5 were added to the 
[125i]Co  n A mixture and the iodination reaction was allowed to proceed with occasional mixing 
for 10 min. The reaction was halted by adding 40/~1 Na2S205  (5 mg/ml) and 30 #l KI  (10 
mg/ml). Unbound 1251 was removed by exhaustive dialysis at room temperature against 1 M 
NaC1; 1 mM KI was present in the initial dialysate. Radioactivity of the [125I]Con A and of 
spleen cells after injection of [125I]Con A into mice was measured in a Packard gamma scintil- 
lation spectrometer (Packard Instrument Co., Inc., Downers Grove, Ill.). Con A content was 
quantified from a dilution curve of trichloroacetic acid-precipitable cpm per ng of [125I]Con A. 
Treatment  of  Spleen  Cells with  Anti-O  Serum  and  Complement.--AKR  anti-0C3H/HeJ 
serum was prepared by the method of Raft (22) and stored at  --20°C until use. The anti-0 
serum used had 90% cytotoxicity titer of 1:250  against C57BL/6  thymus cells by 51Cr re- 
lease assay. Cytotoxic activity against C57BL/6 thymus and spleen cells was completely ab- 
sorbed from the serum by reacting 3 ml serum with brain homogenate from three C3H/HeJ 
mice at 4°C for 1 h  three times. Spleen cells were treated with neat anti-0 serum for 30 min 
at 4°C  (108 cells per ml neat anti-0 serum), washed once with HBSS, and resuspended in 4 
ml of a  1:4 dilution of noncytotoxic guinea pig complement (Baltimore Biological  Labora- 
tories, Baltimore,  Md.)  containing 10  #g/ml deoxyribonuclease (Worthington Biochemical 
Co., St. Louis,  Mo.) per  l0  s cells. Cells were incubated with complement for 30 min at 37°C, 
washed twice in HBSS, and resuspended in medium. Control cells were treated with brain- 
absorbed anti-0 serum  and  complement. PFC  responses in  anti-P-treated C57BL/6  spleen 
cell cultures were restored by addition of 3  )<  10 ~ normal C57BL/6 lymph node cells  (20). 
Cell Irradiation.--Spleen cells were irradiated in plastic Petri dishes with a General Electric 
Maximar 250 Type III X-ray Therapy Unit operating at 250 kVp,  15  mA. Irradiation was 
delivered at 140 R/min through 0.5  mm Cu,  1.0 mm A1 filters.  After irradiation, cells were 
washed in HBSS and resuspended in fresh medium. 208  PII2YTOMITOGENS  AND  ANTIBODY  SYNTI[ESIS 
RESULTS 
Ej~ecls of Phylomilogens on Primary Immune Responses In Vilro.--In an ini- 
tial series of experiments Con A or PHA-P at varying concentrations was added 
at  culture  initiation  to  dissociated  spleen  cell  cultures  stimulated  with 
][0  7 SRBC. Cultures were harvested at 5 days and assayed for IgM PFC. Similar 
results were obtained with both mitogens (Figs. 1 and 2). At submitogenic doses 
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Fro.  1.  Effects of graded doses of Con A added to spleen cell cultures at initiation on the 
5-day primary IgM Pf"C response to SRBC. Data represent means and standard  errors of 
means of four separate experiments normalized to a control response of 1,000 PFC per culture. 
of  15-75 ng Con A  or PHA-P per culture, enhancement of PFC responses of 
about twofold was observed. Conversely, after addition of mitogenic concentra- 
tions of  Con A  or  PHA-P,  150-2,500  ng/culture, PFC  responses  were  pro- 
foundly suppressed. Submitogenic doses of Con A and PHA-P had no effect on 
either total or viable cell recovery at 5 days, whereas mitogenic doses substan- 
tially increased total  cell recovery but had little or no effect on the absolute 
number of viable cells recovered. Similar data were obtained when assays were 
performed at  3  days,  at  the peak of  mitogen-stimulated cell  division, rather 
than at 5 days, when there was little continuing effect of Con A or PHA-P on 
[aH]TdR  incorporation. Addition of  mitogen to  cultures immediateh- before 
assay had no effect on PFC recovery. ROBERT  R.  RICIt  AND  CARL  W.  PIERCE  209 
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FiG.  2.  Effects  of graded  doses of PHA-P  added  to spleen cell  cultures  at initiation  on 
the 5-day primary IgM PFC response to SRBC.  Data represent means and standard errors 
of  means of five separate  experiments normalized  to  a  control response of  1,000  PFC  per 
culture. 
Diverse results  were obtained by varying the  time of mitogen addition  to 
cultures. Treatment of cultures with submitogenic doses of Con A or PHA-P 24 
h  or more after culture initiation had no significant effect on PFC responses. 
However, in contrast with their suppressive effect when added at time 0, mito- 
genie  doses  of both  Con A  and  PHA-P,  as  well  as  PWM,  augmented  PFC 
responses when added at 48 h (Fig. 3). Neither enhancement nor suppression of 
PFC responses was noted after treatment in vitro between 72 and 120 h. The 
enhancement of PFC responses induced by Con A added to cultures at 48 h was 
consistently greater than enhancement observed when either PHA-P or PWM 
was added at this time; mean augmentation after Con A addition was 4.5-fold 
with a range of 2- to 10-fold increase in the PFC response. 
Study of the  kinetics  of PFC  enhancement  after  Con A  addition  at  48 h 
revealed  that  this  effect was manifest  remarkably quickly (Fig.  4).  PFC  re- 
sponses in cultures to which Con A was added immediately before harvesting 
were not different from responses in control cultures. When cultures were har- 220 
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FIG.  3.  Effects  of  adding  mitogens 48  h  after  culture  initiation  on  5-day  primary  IgM 
PFC  responses in  vitro.  Data  represent  mean PFC  responses from  three  experiments nor- 
realized  to a  control response of 1,000 PFC per culture. 
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Fro.  4.  Enhancement of primary IgM PFC response at 48 h  after brief incubation with 
Con A, 0.75 #g/culture, immediately before assay. Data represent means and standard errors 
of  means  of  absolute  PFC/culture  recovered  in  four  experiments  with  eight  individually 
assayed cultures per data point per experiment. 211 
I0 ~ 
vested 1 h after addition of Con A, however, the response was enhanced to 170 % 
of the control value, a difference which was statistically significant with P  < 
0.001 by two-tailed Student's t test. 
The suppressive and enhancing effects of Con A were not unique to spleen cells 
of the C57BL/6 strain which mount vigorous anti-SRBC responses in vitro but 
are relatively poor responders to mitogens as determined by [3H]TdR incorpora- 
tion (23). PFC responses of BALB/c spleen cells, which respond less vigorously 
to SRBC (19) but more actively to Con A and PHA-P, were either suppressed 
(at 0 time) or enhanced (at 48 h) by 0.75/zg/culture Con A, effects analogous to 
those on C57BL/6 cells (Fig. 5). 
It has been reported that although soluble Con A activates only T  cells,  it 
binds equally to T  and B cells (3, 24). Before addition to cultures, Con A solu- 
tions (30 ~g/ml) were absorbed three times at 4'~C for 30 min with bone marrow 
or thymus cells at a final concentration of 20% cells (Table I). Both the suppres- 
sive activity of a mitogenic dose (0.75 ~g/culture) and the enhancing activity of 
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_FIG. 5.  Comparison of effects of Con A on 5-day primary IgM PFC responses to SRBC in 
C57BL/6 and BALB/c spleen cell cultures. Con A, 0.75 #g/culture,  was added at 0,  24,  or 
48 h  incubation. Data represent absolute IgM PFC per culture. 212  PHYTOMITOGENS AND  ANTIBODY  SYNTHESIS 
TABLE I 
Effect of Absorption of Con A with Bone Marrow and Thymus Cells on Con A-Induced 
Modulation oj PFC Responses 
Unabsorbed Con A 
dose ~g/culture 
/gM PFC per culture 
Unabsorbed  BM-absorbed  Thymus-absorbed 
Con A  Con A*  Con A* 
None  1,850 
0.75  500  2,140  2,024 
0.15  1,640  2,844  3,300 
0.075  9,324  2,725  2,100 
0.03  2,824  2,850  2,600 
* Con A solution absorbed three times at 4°C for 30 min with bone marrow (BM) or 
thymus cells at a final concentration of 20% cells. 
a submitogenic dose (0.075 #g/culture) of Con A were absorbed with either cell 
type. As a protein which possesses sites for covalent binding to various carbo- 
hydrates including cross-linked dextran, Con A can also be absorbed from solu- 
tion in this manner (25).  A Con A solution, 40 ml at 300 ~g/ml, was absorbed 
once with  1 g of Sephadex G-75.  Absorbed or unabsorbed solutions were then 
added to SRBC-stimulated cultures at 0 or 48 h and to 1-ml cultures in vertical 
stationary tubes to assay [~H]TdR incorporation. Sephadex absorbed both the 
mitogenic activity and the enhancing activity for PFC responses of mitogenic 
doses of Con A added to cultures at 48 h  (Table II). The suppressive activity 
on PFC responses of the same doses added at culture initiation was also markedly 
reduced although not completely abrogated by a single  Sephadex absorption. 
Effects of Antigen Exposure on Con A-Induced Enhancement of PFC Responses. 
--Experiments were designed to ascertain whether previous activation of spleen 
cells by specific antigen was required for manifestation of enhancement of PFC 
responses by Con A added at 48 h, and whether prior activation by one antigen 
altered the effect of Con A on responses to a second antigen (Table III). Data 
presented are IgM PFC responses to SRBC and HRBC assayed after 5 days in 
culture. The PFC responses in cultures assayed after 7 days were consistently 
lower than 5-day responses whether antigen was added at 0 time or 48 h or both, 
but  the  Con A-induced alteration  of responses  was qualitatively the  same at 
both 5 and 7 days. First, Table IlI notes the effect of Con A, 0.75/xg/culture, 
added at 48 h on background PFC recovery (group A). In the absence of added 
antigen,  background  responses  to  both  SRBC  and  HRBC  were  increased. 
Second,  if  SRBC  was added  48  h  after  culture initiation,  simultaneous  with 
addition of Con A, 0.75  ~g/culture,  enhancement of the  anti-SRBC  PFC  re- 
sponse  was  observed  (group  B).  Finally,  enhancement  of  responses  to  both 
SRBC and HRBC was also observed when either antigen was added at 0 time 
and  the second antigen  was added with 0.75  #g Con A 48 h  later  (group C). ROBERT  R°  RICH  AND  CARL  W.  PIERCE  213 
TABLE  II 
EJ[ect of Absorption  of  Con  A  with Sephadex  G-75  on  Con  A-Induced  Modulation  of PFC 
Responses 
Unabsorbed  Con A 
dose, gg/culture  Absorption*  PttlTdR 
IgM PFC per culture 
Con A 0 h~  Con A 48 h:~ 
cpm 
None  4,480  4,953  4,953 
1.5  --  34,773  83  19,920 
0.75  --  33,596  391  17,440 
0.38  --  6,675  1,227  10,213 
1.5  q-  5,075  1,340  5,147 
0.75  q-  4,440  2,680  5,267 
0.38  q-  6,904  4,693  5,307 
* The Con A solution, 40 ml at 300 #g/ml, was absorbed once at room temperature for 1 
h with 1 g Sephadex G-75. 
:~ Absorbed or unabsorbed Con A solution added to cultures at culture initiation or 48 h 
later. 
TABLE  III 
Role of Antigen Exposure on Enhancement of PFC Responses by Con A  In  Vitro 
Experi-  Con A* 
mental  Time SRBC added  Time HRBC added  (0.75 ~tg/  Anti-SRBC:~ PFC  Anti-HRBC:~ PFC 
group  culture)  per culture  per culture 
A 
h  h 
None  None  --  55  14 
None  None  q-  295  46 
48  None  --  583  -- 
48  None  q-  1,320  -- 
0  None  --  3,600  5 
0  48  --  3,735  212 
0  48  A-  9,750  1,248 
None  0  --  142  705 
48  0  --  668  1,980 
48  0  -}-  1,350  5,160 
* Con A, 0.75 #g/culture, added at 48 h. 
:~ Data represent IgM PFC response to both sheep erythrocytes (SRBC) and horse erythro- 
cytes (HRBC) at 5 days. Erythrocyte antigen dose was 107 erythrocytes per culture. 
These experiments indicated that Con A  expanded the background pool of PFC 
to  both  SRBC  and  HRBC  and  that  prior  activation  of  cultures  by  specific 
antigen was not required  for  manifestation of  Con A-induced enhancement  of 
PFC  responses.  Moreover,  the time of Con A  addition to cultures rather  than 
time of antigen exposure determined the effect of Con A  on antibody  synthesis. 214  Ptt'YTOMITOGENS  AND  ANTIBODY  SYNTHESIS 
Effects of Administration of Con A  In  Vivo on Primary Immune Responses In 
Vitro.--In order to ascertain whether enhancement or suppression of primary 
immune responses in vitro could also be induced by administration of Con A in 
vivo, mice were injected with Con A intravenously 24 h before culture initiation. 
When 107 spleen cells from mice so treated were cultured, effects were similar to 
those obtained by adding Con A  directly to cultures. A  small dose ot  Con A 
(6 #g intravenously, T-l) augmented the PFC response about fourfold, whereas 
a large dose (150 #g intravenously, T-I) caused suppression of the response of 
similar magnitude (Fig. 6). No effect was observed when cultures were estab- 
lished 30 rain after Con A injection. Dose-dependent suppression and enhance- 
ment of PFC responses were both maximal 24 h  after injection of Con A; the 
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FIG.  6.  Suppression or  enhancement of 5-day primary  IgM  PFC  responses to  SRBC  in 
cultures of graded numbers of spleen cells from Con A-injected mice and normal spleen cells. 
All cultures contained a  total of 107 cells. Mice were injected intravenously with 6/zg or  150 
#g Con A  24 h  before preparation of spleen cell suspensions. Data represent means and stand- 
ard errors of means of PFC per culture from four experiments normalized to a control response 
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effects gradually decayed as the  interval  between  Con A  administration  and 
culture initiation  was increased to 5 days. 
Fig. 6 also illustrates  the result of mixing normal spleen cells with cells from 
mice injected with Con A  24 h previously. All cultures contained a  total of 107 
cells with graded increments from 1 to 100 % of the cells being derived from Con 
A-treated mice. Synergistic enhancement of PFC responses was observed when 
small numbers of cells from mice injected  with 6 #g Con A  were mixed with 
larger numbers of normal  cells.  As few as  105 spleen  cells from mice injected 
with 6  #g of Con A  approximately doubled PFC  responses when mixed with 
9.9 >(  106 normal spleen cells. When 1 )< 106 cells from Con A-treated mice were 
mixed with 9  X  106 normal cells, the response was enhanced about 2.5-fold. As 
previously noted,  a pure inoculum of Con A-treated cells had a  PFC response 
approximately four times greater than that of untreated control cells. Interest- 
ingly, despite the substantial  suppression of responses in cultures of l0  T spleen 
cells from recipients of 150 #g of Con A, enhancement of about 2.5-fold, rather 
than suppression,  was observed when 105 of these cells were mixed with 9.9 X 
106 normal spleen cells. 
It was thought that the enhancement of PFC responses observed when small 
numbers of cells from Con A-treated mice were mixed with much larger numbers 
of normal cells could have been due to transfer of Con A to the cultures with the 
spleen cells,  rather than the consequence of activation of the small number of 
Con A-treated cells  themselves.  This problem  was approached  by the direct 
measurement of the amount of [125I]Con A present in 105 spleen cells from mice 
injected 24 h  before with various doses of [125I]Con A  (Table IV). When these 
data are compared with the Con A  dose-response curve (Fig.  1), it is apparent 
that  the  amount of [125I]Con A  transferred  with  105 Con A-treated cells 24 h 
after  injection  of  150 #g was at  least  one order  of magnitude  less  than  that 
required for enhancement of PFC responses when Con A was added directly to 
cultures.  Moreover, after injection of 6/~g,  insufficient Con A  was transferred 
24 h later to affect PFC responses at any cell dose up to 107/culture. 
TABLE IV 
Amount of [125I]Con A  in 105 Spleen  Cells 24 h After Intravenous  Injection 
Con A  dose injected  [12~I] Con A per 10  5 spleen cells* 
vg  ng 
1  0.0024  ±  0.0004 
6  0.0276  ±  0.0016 
30  0.2259  ±  0.0149 
150  1.5756  ±  0.1292 
* Data represent  the means and standard  errors  of the means of ng [125I]Con  A in  105 
spleen cells from four mice per dose injected with [125I]Con  A 24 h previously. Trichloroacetic 
acid-precipitable cpm in 105 spleen cells were converted to nanograms Con A from a stand- 
ard curve of trichloroacetic acid-precipltable cpm in known  [125I]Con  A solutions. 216  PEIYTOMITOGENS  AND  ANTIBODY  SYNTI-IESIS 
Further characterization of the cell population mediating enhancement solidi- 
fied the argument that transferred Con A  did not account for the synergistic 
enhancement of  PFC  responses  observed  when  mixing normal  and  Con  A- 
treated spleen cells. Spleen cells from mice injected with 6 jug Con A were treated 
with anti-0C3H serum and complement before mixing with normal cells. Control 
Con A-treated cells were exposed  to brain-absorbed anti-0 serum and comple- 
ment. Treatment with unabsorbed anti-0 serum and complement completely 
abolished the 2- to 2},~-fold  enhancement of responses mediated by control Con 
A-treated cells (Table V). The effectiveness of treatment with anti-0 serum and 
complement was demonstrated by the profound suppression of PFC responses 
in cultures of 107 anti-0-treated cells from Con A-injected mice. 
Characteristics of  Con A-activated cells with  enhancing activity were  also 
delineated by exposure of these cells to 2000 R  X-irradiation 24 h afterinjection 
of 6 jug Con A in vivo and before mixing with normal cells (Fig. 7). Irradiation 
completely  abolished the capacity of  these  cells cultured alone to  mount an 
immune response. However, the magnitude of enhancement of PFC responses 
of normal spleen cells induced by 10  ~ to 106 spleen cells from Con A-treated an- 
imals was not altered by 2,000 R  irradiation. 
Effects  of Con  A  on  IgG  PFC  Responses.--The  foregoing data represent ob- 
servations of the effects of phytomitogens on IgM PFC responses. It clearly was 
TABLE  V 
Effect  of Anti 0C311  and Complement  Treatment of Spleen  Cells from Mice Injected with Con 
A  24 h Previously on Their Ability To Enhance PFC Responses by Normal Spleen Cells 
Con A spleen 
Normal cells per  cells per culture  Treatment of Con A cells*  IgM PFC per 
culture X  10  6  X  I0  -6  culture1: 
10  Spleen  0  1,000 
9.9 Spleen  0.1  Brain-absorbed anti-0 -b C  1,570 
9.8  "  0.2  ......  --  "  1,603 
9.5  "  0.5  "  ....  +  "  2,066 
9  "  1.0  ......  q- "  1,907 
0  "  10.0  ......  +  "  2,623 
9.9 Spleen  0.1  Anti-0 q- C  980 
9.8  "  0.2  "  q- "  986 
9.5  "  0.5  "  -- "  1,120 
9  "  1.0  "  --  "  1,140 
0  "  10.0  "  +  "  58 
* Spleen cells from mice injected intravenously 24 h before with 6/zg Con A were treated 
with  neat AKR anti4?C3H or  brain-absorbed anti-0C3H for 30 min at 37°C, l0  s cells/ml 
antiserum.  Cells were then washed and incubated for 30 min at 37°C with 1:4 guinea pig 
complement containing 10 ~g/ml deoxyribonuclease. 
Data represent means of IgM PI"C per culture from three separate experiments. Data 
have been normalized to a control response of 1,000 PFC per culture. ROBERT  R.  RICH  AND  CARL  W.  PIERCE 
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Flc.  7.  Radiation  resistance of the enhancing effect of small numbers of spleen cells from 
Con A-injected mice on IgM PFC  responses of normal spleen cells. All cultures contained a 
total of l0 T cells. Mice were injected intravenously with 6  #g Con A  24 h  before preparation 
of spleen cell suspensions. Cells were  exposed  to  2,000  R  X-irradiation  immediately before 
mixing with normal spleen cells in culture. Data represent means and standard errors of means 
from three separate experiments normalized to  a  control response of 1,000 PFC  per culture. 
important to establish whether these effects were confined  to the IgM response 
or  whether  synthesis  of antibodies  in  other  immunoglobulin  classes was also 
affected. Spleen cells were consequently treated either in vitro or in vivo with 
Con A doses and regimens previously shown to enhance or suppress IgM synthe- 
sis, and assays for IgM and IgG PFC were performed in parallel (Table VI). In 
all experiments the effects on IgM and IgG antibody responses were concordant. 
Both suppression and enhancement of IgG PFC development were observed and 
the direction of change was consistently the same as the effect on IgM responses. 
DISCUSSION 
These experiments demonstrate that the nonspecific phytomitogens can sub- 
stantially enhance or suppress primary PFC  responses to heterologous erythro- 
cytes in vitro. The effects can be obtained by administration of mitogen either 218  PI-IYTOMITOGENS  AND  ANTIBODY  SYNTHESIS 
TABLE  VI 
Effect  of  Con  A  on  IgG  PFC  Responses  In  Vitro 
Con A  PFC response* 
Treatment  mode  Dose  Time of Con A  IgM  IgG  treatment 
~g  h 
--  None  1,000  200 
In vitro  0.75  0  27  8 
In vitro  0.75  48  2,365  906 
In vivo  6.0  --24  2,213  632 
In vivo  150.0  --24  84  43 
* Data  represent  means  of  IgM  and  IgG  PFC  per  culture from  three separate  experi- 
ments. Data have been  normalized to  control  responses  of  1,000  IgM  PFC  and  200  IgG 
PFC per culture. 
in vivo or in vitro and is critically dependent upon both dose and time of mitogen 
treatment. A  small number of mitogen-activated radioresistant T  cells derived 
from mice injected  with  Con  A  enhance  the  PFC  responses  of  much  larger 
numbers  of normal  spleen  cells.  The  mechanisms of  the  modulation of PFC 
responses by mitogen-activated T  cells are not as yet clear. Our  observations, 
however,  are  consistent  with presently emerging concepts of T  cell-mediated 
control of antibody synthesis by B cells (17). 
Suppression  of PFC  responses  generally followed  treatment  of spleen  cells 
with mitogenic doses of Con A or PHA before or concomitant with culture  ini- 
tiation. Suppression was not due simply to elaboration of toxic substances into 
the culture medium since  10-fold suppression of PFC  responses was not  asso- 
ciated with reduction in viable cell recovery. Moreover, suppression was mani- 
fest both during and  after the period of intense mitogenic activity in  the cul- 
tures. Studies with [12aI]Con A established that suppression of antibody synthe- 
sis was a secondary effect mediated by activated T  lymphocytes rather than a 
direct effect of mitogen-lymphocyte interaction. This was demonstrated by the 
substantial  inhibition  of PFC  responses in  cultures  where  equal  numbers  of 
normal spleen cells and spleen cells from mice injected with 150/zg Con A  24 h 
previously were mixed. These cultures contained approximately 80 ng of Con A, 
which was transferred with the spleen cells from Con A-injected mice and was a 
dose of Con A  which  enhanced  rather  than  suppressed PFC  responses when 
added directly to cultures. These data support recent observations from several 
laboratories  that  a  population  of  thymus  or  thymus-derived  lymphocytes 
stimulated with soluble antigens (26  31) or allogeneic cells (32)  can suppress B 
cell responses to antigen. Although this "suppressor" T  cell function remains, as 
yet, poorly understood,  concordance  of  the  suppression  and  enhancement  of 
both IgM and IgG PFC responses in the present experiments is important since 
it suggests that the regulatory function of T  cells involves direct quantitative ROBERT  R.  RICI-I  AND  CARL  W.  PIERCE  219 
control of antibody production rather than a permissive effect on synthesis of 
one class of antibody and consequent negative feedback on another class of 
antibody. 
The cell population mediating enhancement of PFC  responses when large 
numbers of normal spleen cells were nlixed with much smaller numbers of cells 
from Con A-injected mice was more fully characterized. The data clearly indi- 
cate that  this enhancing effect was mediated by activated T  cells since it was 
completely and specifically abrogated by treatment of the cells from Con A- 
injected animals with anti-0 serum and complement before mixing with normal 
cells. Although susceptible to treatment with anti-0 serum, the capacity of these 
cells to enhance PFC  responses of normal  cells was  resistant  to  2,000  R  X- 
irradiation. In both respects, therefore, these cells are entirely similar to anti- 
gen-induced T helper ceils described by others (17, 33-36). 
Of particular interest are the paradoxical effects on PFC responses of adding 
to cultures small versus large numbers of spleen cells from mice injected 24 h 
previously with 150/~g  Con A. Although PFC responses in cultures containing 
50 % or more of these cells were markedly suppressed, addition of 105 cells from 
these mice to cultures of 9.9 X  106 normal cells resulted in 2.5-fold enhancement 
of PFC responses. These observations suggest that the two effects, enhancement 
and suppression of PFC responses, may be mediated by a single population of 
regulatory T  cells which promote antibody synthesis when present  in  small 
numbers and inhibit antibody synthesis when present in larger numbers. Alter- 
natively, these same effects might be observed if two populations of cells with 
antagonistic  functions were  involved.  If  the  frequency of helper  cells  were 
greater, but the potency per cell less than that of suppressor cells,  at limiting 
dilutions the net effect of two antagonistic populations would be enhancement, 
whereas suppression would be the net result obtained with larger numbers of 
cells. 
Andersson and coworkers (4) have observed that B lymphocytes proliferate 
when stimulated by Con A in the presence of humoral factors released by thy- 
mocytes. It is therefore conceivable that the enhancing activity of a mitogenic 
dose of Con A added after 48 h in culture reflected a direct effect of Con A on 
antibody-producing cells or their precursors. The progressive functional loss of 
the ~-alloantigen from cultured T cells  2 precluded analysis of derivation of cells 
activated by mitogens added to cultures at 48 h since T  cells could not effec- 
tively be killed with anti-0 serum and complement at this time. It is apparent, 
however, that the enhancement of PFC responses did not depend entirely on 
mitogenesis in the responding clone of B cells since significant enhancement of 
PFC responses occurred within 1 h of addition of Con A to cultures at 48 h. This 
is  many hours before DNA  synthesis or  cell  replication  can  be  detected in 
2 Pierce,  C. W.  1972. Immune responses in vitro. VII.  Loss of susceptibility of functional 
P-bearing cells to cytotoxic action of anti-~ serum and complement in vitro.  Submitted for 
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mitogen-stimulated  cultures  (37)  but  is  consistent  with  the  observed early 
increases in protein  and RNA  synthesis  (38-41).  Moreover,  enhancement of 
PFC responses after addition of submitogenic doses of Con A at culture initia- 
tion was also observed. These latter data emphasize that the nonspecific mito- 
gens may have important effects on lymphocyte functions at doses insufficient 
to cause DNA replication, mitosis, or blast transformation. 
The time-course of enhancement of PFC responses after addition of Con A to 
cultures at 48 h  suggests possible mechanisms of this effect. In these circum- 
stances Con A might stimulate active antibody synthesis earlier by committed 
precursors of PFC which, in the absence of Con A, would begin to secrete anti- 
body somewhat later. Alternatively, Con A might provoke, either directly or via 
a  T  cell  mediator,  antibody synthesis by cells of marginal  specificity for the 
stimulating antigen. Detailed studies, currently in progress, of the kinetics of 
PFC development should help delineate the correct mechanism.  The increased 
recovery of background PFC  to both SRBC  and HRBC  in vitro and the pre- 
viously reported increase in background PFC  after administration of PHA in 
vivo (42, 43) provide indirect support for the latter hypothesis. 
It  is  apparent  that  further study of mitogen-induced  effects on  antibody 
synthesis will provide important information regarding regulatory mechanisms 
in immune responses. Experiments similar to those exploiting mitogen-induced 
lymphocyte activation for delineation of T  cell functions  in cellular immunity 
are in progress. In particular, the model should be useful in the investigation of 
soluble factors released from activated T  cells which modulate and control anti- 
body synthesis and in studies designed to establish the identity of or differences 
between cells or soluble cell products which mediate suppressor or helper T  cell 
functions. 
SUMMARY 
The  effects of  nonspecific phytomitogens on  primary  plaque-forming  cell 
(PFC) responses of mouse spleen cells to heterologous erythrocytes in vitro were 
studied. Spleen cell cultures treated with concanavalin A or phytohemagglutinin 
in vitro or established with spleen cells derived from mice injected with con- 
canavalin A 24 h previously were similarly affected. In both cases, submitogenic 
doses resulted in substantial  enhancement of PFC responses, whereas  10-fold 
larger doses were profoundly inhibitory. In contrast to the suppressive effects of 
mitogenic doses of phytomitogens added at culture initiation, addition of these 
same  doses  to cultures 48  h  later resulted in increased PFC  responses.  This 
enhancement could be observed within  1 h  after treatment and consequently 
could not be ascribed only to mitotic expansion of the antibody-synthesizing 
clone. Activation of spleen cells with specific antigen before mitogen treatment 
was not required for expression of the enhancing or suppressing effects on PFC 
responses. IgM and IgG PFC responses were similarly affected. Studies of cell 
interactions revealed that as few as 10  a spleen cells obtained from mice treated ROBERT R.  RICtt  AND CARL W.  PIERCE  221 
with concanavalin A in vivo synergistically enhanced the PFC responses of 107 
normal  spleen  cells.  This enhancement  was mediated by mitogen-activated T 
lymphocytes which were resistant  to 2000 R  irradiation  24 h  after activation. 
The relevance of these observations to emerging concepts of helper and suppres- 
sor T  cell activity is discussed. 
We are deeply grateful to Professor Baruj Benaceiraf for his interest, encouragement, and 
advice during the course of these experiments. 
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